title: The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex.
abstract: Von Willebrand disease, the most common hereditary bleeding disorder, arises from quantitative or qualitative defect of von Willebrand factor (VWF). The aim of the treatment is to correct the dual defect of hemostasis caused by the abnormal/reduced VWF and the concomitant deficiency of factor VIII (FVIII). The synthetic vasopressin analogue desmopressin is the mainstay of therapy in about 80% of patients, while nearly 20% are unresponsive and must be treated with FVIII/VWF concentrates. This latter therapeutic option will be focused in the review, with particular consideration to the management of surgery and invasive procedures in these patients.
authors.affiliation: Servizio di Immunoematologia e Trasfusione - Centro Emofilia, Azienda Ospedaliera di Verona.
authors.forename: Massimo
authors.initials: M
authors.lastname: Franchini
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Lippi
references.citation: Blood. 2002 Jan 15;99(2):450-6
references.pmid: 11781224
references.citation: J Thromb Haemost. 2007 Jul;5(7):1420-30
references.pmid: 17439628
references.citation: Haemophilia. 2004 Oct;10 Suppl 4:169-76
references.pmid: 15479393
references.citation: Blood. 2001 Apr 1;97(7):1915-9
references.pmid: 11264151
references.citation: Haemophilia. 1998;4 Suppl 3:48-52
references.pmid: 10028319
references.citation: Am J Hematol. 2001 Apr;66(4):280-4
references.pmid: 11279640
references.citation: Thromb Haemost. 1998 Mar;79(3):456-65
references.pmid: 9531024
references.citation: Haemophilia. 2004 May;10(3):199-217
references.pmid: 15086318
references.citation: Haemophilia. 2004 Jan;10(1):42-51
references.pmid: 14962219
references.citation: Crit Rev Clin Lab Sci. 2007;44(2):115-49
references.pmid: 17364690
references.citation: Best Pract Res Clin Haematol. 2001 Jun;14(2):257-79
references.pmid: 11686099
references.citation: Haematologica. 2007 Jul;92(7):944-51
references.pmid: 17606445
references.citation: J Thromb Haemost. 2007 Jun;5(6):1115-24
references.pmid: 17403090
references.citation: Haemophilia. 2002 Sep;8(5):607-21
references.pmid: 12199668
references.citation: Haemophilia. 2003 Nov;9(6):688-95
references.pmid: 14750934
references.citation: Haemophilia. 2001 Jan;7 Suppl 1:10-5
references.pmid: 11240613
references.citation: N Engl J Med. 2000 Aug 17;343(7):457-62
references.pmid: 10950667
references.citation: N Engl J Med. 2004 Aug 12;351(7):683-94
references.pmid: 15306670
references.citation: Blood. 1987 Feb;69(2):454-9
references.pmid: 3492222
references.citation: Haematologica. 2003 Nov;88(11):1279-83
references.pmid: 14607757
references.citation: Haematologica. 2003 Jan;88(1):94-108
references.pmid: 12551832
references.citation: Thromb Haemost. 2002 Feb;87(2):224-30
references.pmid: 11858481
references.citation: Haemophilia. 2002 Nov;8(6):761-7
references.pmid: 12410644
references.citation: Haemophilia. 2000 Jul;6 Suppl 1:60-7
references.pmid: 10982270
references.citation: Haemophilia. 1998;4 Suppl 3:33-9
references.pmid: 10028316